Abstract
Background Racial disparities in outcomes of non-small-cell lung cancer (NSCLC) patients in the United States are well documented. A retrospective analysis of patients in the Veterans Affairs Central Cancer Registry was conducted to determine whether similar disparities exist in a population with a single-payer, accessible health care system. Patients and Methods Demographic data of patients diagnosed with NSCLC between January 1995 and February 2009 were analyzed using Kruskal-Wallis test or the χ2 test. Multivariate Cox proportional hazards regression analysis was used to compare survival among races. Results Of the 82,414 patients, 98% were male, 82% had a smoking history, and 81% were Caucasian. Caucasian individuals had better prognostic features compared with African-American individuals (stage I/II [24% vs. 21%]; Grade I/II [21% vs. 17%]). A larger proportion of Caucasian compared with African-American individuals received stage-appropriate treatment (surgery for stage I [48% vs. 41%; P
| Original language | English |
|---|---|
| Pages (from-to) | 152-158 |
| Number of pages | 7 |
| Journal | Clinical Lung Cancer |
| Volume | 15 |
| Issue number | 2 |
| DOIs | |
| State | Published - Mar 2014 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Cancer Research
- Oncology
- Pulmonary and Respiratory Medicine
- Medicine(all)
Cite this
Association between race and survival of patients with non-small-cell lung cancer in the united states veterans affairs population. / Ganti, Apar Kishor; Subbiah, Shanmuga P.; Kessinger, Anne; Gonsalves, Wilson I.; Silberstein, Peter T.; Loberiza, Fausto R.
In: Clinical Lung Cancer, Vol. 15, No. 2, 03.2014, p. 152-158.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Association between race and survival of patients with non-small-cell lung cancer in the united states veterans affairs population
AU - Ganti, Apar Kishor
AU - Subbiah, Shanmuga P.
AU - Kessinger, Anne
AU - Gonsalves, Wilson I.
AU - Silberstein, Peter T.
AU - Loberiza, Fausto R.
PY - 2014/3
Y1 - 2014/3
N2 - Background Racial disparities in outcomes of non-small-cell lung cancer (NSCLC) patients in the United States are well documented. A retrospective analysis of patients in the Veterans Affairs Central Cancer Registry was conducted to determine whether similar disparities exist in a population with a single-payer, accessible health care system. Patients and Methods Demographic data of patients diagnosed with NSCLC between January 1995 and February 2009 were analyzed using Kruskal-Wallis test or the χ2 test. Multivariate Cox proportional hazards regression analysis was used to compare survival among races. Results Of the 82,414 patients, 98% were male, 82% had a smoking history, and 81% were Caucasian. Caucasian individuals had better prognostic features compared with African-American individuals (stage I/II [24% vs. 21%]; Grade I/II [21% vs. 17%]). A larger proportion of Caucasian compared with African-American individuals received stage-appropriate treatment (surgery for stage I [48% vs. 41%; P
AB - Background Racial disparities in outcomes of non-small-cell lung cancer (NSCLC) patients in the United States are well documented. A retrospective analysis of patients in the Veterans Affairs Central Cancer Registry was conducted to determine whether similar disparities exist in a population with a single-payer, accessible health care system. Patients and Methods Demographic data of patients diagnosed with NSCLC between January 1995 and February 2009 were analyzed using Kruskal-Wallis test or the χ2 test. Multivariate Cox proportional hazards regression analysis was used to compare survival among races. Results Of the 82,414 patients, 98% were male, 82% had a smoking history, and 81% were Caucasian. Caucasian individuals had better prognostic features compared with African-American individuals (stage I/II [24% vs. 21%]; Grade I/II [21% vs. 17%]). A larger proportion of Caucasian compared with African-American individuals received stage-appropriate treatment (surgery for stage I [48% vs. 41%; P
UR - http://www.scopus.com/inward/record.url?scp=84894052887&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84894052887&partnerID=8YFLogxK
U2 - 10.1016/j.cllc.2013.11.004
DO - 10.1016/j.cllc.2013.11.004
M3 - Article
VL - 15
SP - 152
EP - 158
JO - Clinical Lung Cancer
JF - Clinical Lung Cancer
SN - 1525-7304
IS - 2
ER -